The two new codes, per the AMA’s CPT editorial panel, are:
87636: “Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus types A and B, multiplex amplified probe technique.”
87637: “Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A and B, and respiratory syncytial virus, multiplex amplified probe technique.”
The editorial panel also revised CPT codes ranging from 87301 to 87430 to remove the undefined term “multi step method” from code descriptors.
The codes have been approved for immediate use.
More articles on healthcare finance:
M Health Fairview to lay off 900, close hospital ED
Investors extracted $400M from hospital chain that couldn’t afford supplies
7 hospitals with strong finances
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.